World Metastatic Prostate Cancer Drug Landscape Research
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Advanced Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The
PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST
Learn about disparities in the use of second-generation androgen receptor inhibitors for prostate cancer and how to improve outcomes.
Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.
/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced grants awarded for developing innovative...